Cost-utility analysis and eligibility of dapagliflozin for patients with heart failure across the whole spectrum of ejection fraction

被引：0
|
作者：
Kim, E. S. [1 ]
Park, S. K. [2 ]
Youn, J. C. [3 ]
Lee, H. Y. [4 ]
Kim, M. S. [5 ]
Choi, J. O. [6 ]
Kang, S. M. [7 ]
Yoo, B. S. [8 ]
Choi, D. J. [9 ]
Oh, B. H. [10 ]
Baek, S. H. [3 ]
机构：
[1] Korea Adv Inst Sci & Technol, Daejeon, South Korea
[2] Catholic Univ Korea, Coll Pharm, Bucheon, South Korea
[3] Catholic Univ Korea, Div Cardiol, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[5] Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[6] Samsung Med Ctr, Dept Internal Med, Seoul, South Korea
[7] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[8] Wonju Severance Christian Hosp, Dept Internal Med, Wonju, South Korea
[9] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea
[10] Mediplex Sejong Hosp, Dept Internal Med, Incheon, South Korea
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [1] Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea
    Kim, Eui-Soon
    Park, Sun-Kyeong
    Cho, Daniel Sung-ho
    Youn, Jong-Chan
    Lee, Hye Sun
    Lee, Hae-Young
    Cho, Hyun-Jai
    Choi, Jin-Oh
    Jeon, Eun-Seok
    Lee, Sang Eun
    Kim, Min-Seok
    Kim, Jae-Joong
    Hwang, Kyung-Kuk
    Cho, Myeong-Chan
    Chae, Shung Chull
    Kang, Seok-Min
    Park, Jin Joo
    Choi, Dong-Ju
    Yoo, Byung-Su
    Cho, Jae Yeong
    Kim, Kye Hun
    Oh, Byung-Hee
    Greenberg, Barry
    Baek, Sang Hong
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, 24 (02) : 313 - 324
  • [2] Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea
    Eui-Soon Kim
    Sun-Kyeong Park
    Daniel Sung-ho Cho
    Jong-Chan Youn
    Hye Sun Lee
    Hae-Young Lee
    Hyun-Jai Cho
    Jin-Oh Choi
    Eun-Seok Jeon
    Sang Eun Lee
    Min-Seok Kim
    Jae-Joong Kim
    Kyung-Kuk Hwang
    Myeong-Chan Cho
    Shung Chull Chae
    Seok-Min Kang
    Jin Joo Park
    Dong-Ju Choi
    Byung-Su Yoo
    Jae Yeong Cho
    Kye Hun Kim
    Byung-Hee Oh
    Barry Greenberg
    Sang Hong Baek
    American Journal of Cardiovascular Drugs, 2024, 24 : 313 - 324
  • [3] Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction
    Krittayaphong, Rungroj
    Permsuwan, Unchalee
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 322 : 183 - 190
  • [4] Cost-utility analysis of add-on dapagliflozin in heart failure with reduced ejection fraction in the Philippines
    Mendoza, Victor L.
    Tumanan-Mendoza, Bernadette A.
    Punzalan, Felix Eduardo R.
    ESC HEART FAILURE, 2021, 8 (06): : 5132 - 5141
  • [5] Cost-utility analysis of add-on dapagliflozin in heart failure with reduced ejection fraction in the Philippines
    Mendoza, Victor L.
    Tumanan-Mendoza, Bernadette A.
    Punzalan, Felix Eduardo R.
    ESC HEART FAILURE, 2022, 8 (06): : 5132 - 5141
  • [6] Cost-utility analysis of add-on dapagliflozin in heart failure with preserved or mildly reduced ejection fraction
    Tang, Yi
    Sang, Haiqiang
    ESC HEART FAILURE, 2023, 10 (04): : 2524 - 2533
  • [7] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE IN PANAMA
    Ordonez, J.
    Gonzales, L.
    Romero, A.
    Effio, J.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    VALUE IN HEALTH, 2022, 25 (07) : S403 - S403
  • [8] Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction Spectrum
    Butt, Jawad H.
    Docherty, Kieran F.
    Claggett, Brian L.
    Desai, Akshay S.
    Fang, James C.
    Petersson, Magnus
    Langkilde, Anna Maria
    de Boer, Rudolf A.
    Honorio, Jose Walter Cabrera
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Kober, Lars
    Lam, Carolyn S. P.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Vardeny, Orly
    O'Meara, Eileen
    Saraiva, Jose F. K.
    Shah, Sanjiv J.
    Vaduganathan, Muthiah
    Jhund, Pardeep S.
    Solomon, Scott D.
    McMurray, John J. V.
    JACC-HEART FAILURE, 2023, 11 (04) : 375 - 388
  • [9] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE IN COSTA RICA
    Ordonez, J.
    Quesada Chaves, D. F.
    Rodriguez, M.
    Poveda, J.
    Speranza, M.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    VALUE IN HEALTH, 2022, 25 (07) : S360 - S360
  • [10] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE IN DOMINICAN REPUBLIC
    Ordonez, J.
    Cruz, L.
    Feliz, E.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    VALUE IN HEALTH, 2022, 25 (07) : S383 - S383
12345